Personalized Neoantigen Vaccine Induces Continued Responses in Pretreated, Advanced HCC
Intradermal injection with GNOS-PV02 plus plasmid-encoded interleukin-12 followed by electroporation elicited complete molecular response detected via circulating tumor DNA in 4 additional patients as second-line therapy in patients with advanced hepatocellular carcinoma.
Source: onclive.com